Cite Filings / APVO / 0001649553-26-000098

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Aptevo Therapeutics Inc. Filed 2026-08-14 Acc 0001649553-26-000098

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-12 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-14 10-Q Quarterly Report
2026-08-14 8-K Results of operations
2026-08-13 8-K Material agreement · Unregistered share sale · Other events
2026-08-10 4 President and CEO acquired 961 shares (option exercise)
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…